{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:26:57Z","timestamp":1783711617572,"version":"3.55.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T00:00:00Z","timestamp":1317945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0026098","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T22:05:50Z","timestamp":1318025150000},"page":"e26098","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts"],"prefix":"10.1371","volume":"6","author":[{"given":"Kevin","family":"Kemp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Witherick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Scolding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,10,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich&apos;s ataxia.","volume":"335","author":"A Durr","year":"1996","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich&apos;s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.","volume":"271","author":"V Campuzano","year":"1996","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/hmg\/ddi461","article-title":"Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity.","volume":"15","author":"O Gakh","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2007.05.009","article-title":"Advancements in the pathophysiology of Friedreich&apos;s Ataxia and new prospects for treatments.","volume":"92","author":"NE Babady","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/513887","article-title":"Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat.","volume":"61","author":"E Monros","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncpneuro0704","article-title":"Drug Insight: antioxidant therapy in inherited ataxias.","volume":"4","author":"M Pandolfo","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2147\/NDT.S6916","article-title":"Current and emerging treatment options in the management of Friedreich ataxia.","volume":"6","author":"M Mancuso","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue of the Friedreich&apos;s ataxia knockout mouse by human YAC transgenesis.","volume":"3","author":"MA Pook","year":"2001","journal-title":"Neurogenetics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12311-008-0036-x","article-title":"Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression.","volume":"7","author":"F Acquaviva","year":"2008","journal-title":"Cerebellum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2362.2005.01568.x","article-title":"Recombinant human erythropoietin: effects on frataxin expression in vitro.","volume":"35","author":"B Sturm","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21177","article-title":"Friedreich&apos;s ataxia: clinical pilot trial with recombinant human erythropoietin.","volume":"62","author":"S Boesch","year":"2007","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1958","DOI":"10.1371\/journal.pone.0001958","article-title":"HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.","volume":"3","author":"M Rai","year":"2008","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nchembio815","article-title":"Histone deacetylase inhibitors reverse gene silencing in Friedreich&apos;s ataxia.","volume":"2","author":"D Herman","year":"2006","journal-title":"Nat Chem Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e8825","DOI":"10.1371\/journal.pone.0008825","article-title":"Two new pimelic diphenylamide HDAC inhibitors induce sustained frataxin upregulation in cells from Friedreich&apos;s ataxia patients and in a mouse model.","volume":"5","author":"M Rai","year":"2010","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1705757","article-title":"Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury.","volume":"40","author":"AM Parr","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12015-010-9178-6","article-title":"Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells.","volume":"6","author":"K Kemp","year":"2010","journal-title":"Stem Cell Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1471-4159.2009.06553.x","article-title":"Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.","volume":"114","author":"K Kemp","year":"2009","journal-title":"J Neurochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.scr.2009.02.006","article-title":"Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.","volume":"3","author":"A Wilkins","year":"2009","journal-title":"Stem Cell Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis.","volume":"198","author":"L Crigler","year":"2006","journal-title":"Exp Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1471-4159.2009.06268.x","article-title":"Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo.","volume":"110","author":"C Lanza","year":"2009","journal-title":"J Neurochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2990.2010.01122.x","article-title":"Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.","volume":"37","author":"K Kemp","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1352458510371959","article-title":"Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.","volume":"16","author":"E Mallam","year":"2010","journal-title":"Mult Scler"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12311-008-0084-2","article-title":"Friedreich&apos;s Ataxia: from the (GAA)n repeat mediated silencing to new promising molecules for therapy.","volume":"8","author":"D Marmolino","year":"2009","journal-title":"Cerebellum"},{"key":"ref24","first-page":"1251","article-title":"Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion.","volume":"60","author":"SI Bidichandani","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.","volume":"6","author":"V Campuzano","year":"1997","journal-title":"Hum Mol Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/jnnp.2003.028605","article-title":"Real time PCR quantification of frataxin mRNA in the peripheral blood leucocytes of Friedreich ataxia patients and carriers.","volume":"75","author":"L Pianese","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich&apos;s ataxia: a randomised, placebo-controlled trial.","volume":"6","author":"NA Di Prospero","year":"2007","journal-title":"Lancet Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e10025","DOI":"10.1371\/journal.pone.0010025","article-title":"PGC-1alpha down-regulation affects the antioxidant response in Friedreich&apos;s ataxia.","volume":"5","author":"D Marmolino","year":"2010","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2377-8-20","article-title":"Deferiprone targets aconitase: implication for Friedreich&apos;s ataxia treatment.","volume":"8","author":"S Goncalves","year":"2008","journal-title":"BMC Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/emmm.201000064","article-title":"Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation.","volume":"2","author":"T Punga","year":"2010","journal-title":"EMBO Mol Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tig.2009.04.007","article-title":"Instability and chromatin structure of expanded trinucleotide repeats.","volume":"25","author":"V Dion","year":"2009","journal-title":"Trends Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddn127","article-title":"Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.","volume":"17","author":"K Li","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1007\/s12311-011-0287-9","article-title":"Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia - a Dose-Response Trial.","author":"W Nachbauer","year":"2011"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.23435","article-title":"Epoetin alfa increases frataxin production in Friedreich&apos;s ataxia without affecting hematocrit.","volume":"26","author":"F Sacca","year":"2011","journal-title":"Mov Disord"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0014-5793(97)00734-5","article-title":"Deletion of the yeast homologue of the human gene associated with Friedreich&apos;s ataxia elicits iron accumulation in mitochondria.","volume":"411","author":"F Foury","year":"1997","journal-title":"FEBS Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/hmg\/8.3.425","article-title":"The Friedreich&apos;s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.","volume":"8","author":"A Wong","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.108.046847","article-title":"Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich&apos;s ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.","volume":"74","author":"CK Lim","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e4253","DOI":"10.1371\/journal.pone.0004253","article-title":"Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.","volume":"4","author":"V Paupe","year":"2009","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/10.19.2061","article-title":"Disabled early recruitment of antioxidant defenses in Friedreich&apos;s ataxia.","volume":"10","author":"K Chantrel-Groussard","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1074\/jbc.M408717200","article-title":"Friedreich&apos;s ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?","volume":"280","author":"B Sturm","year":"2005","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1531-8249(199905)45:5<673::AID-ANA20>3.0.CO;2-Q","article-title":"Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia.","volume":"45","author":"MB Delatycki","year":"1999","journal-title":"Ann Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/15230860050192233","article-title":"Sensitivity of FRDA lymphoblasts to salts of transition metal ions.","volume":"2","author":"A Wong","year":"2000","journal-title":"Antioxid Redox Signal"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.","volume":"27","author":"H Puccio","year":"2001","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/adc.86.5.376","article-title":"Antioxidant enzymes in blood of patients with Friedreich&apos;s ataxia.","volume":"86","author":"G Tozzi","year":"2002","journal-title":"Arch Dis Child"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/hmg\/11.7.815","article-title":"Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro.","volume":"11","author":"SA Shoichet","year":"2002","journal-title":"Hum Mol Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1046\/j.1365-2362.2001.00922.x","article-title":"Glutathione in blood of patients with Friedreich&apos;s ataxia.","volume":"31","author":"F Piemonte","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","article-title":"Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich&apos;s ataxia.","volume":"233","author":"V Calabrese","year":"2005","journal-title":"J Neurol Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e6379","DOI":"10.1371\/journal.pone.0006379","article-title":"The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.","volume":"4","author":"N Calmels","year":"2009","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1073\/pnas.0709691105","article-title":"Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich&apos;s ataxia.","volume":"105","author":"PR Anderson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-003-0170-z","article-title":"Friedreich ataxia-update on pathogenesis and possible therapies.","volume":"5","author":"M Voncken","year":"2004","journal-title":"Neurogenetics"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.","volume":"11","author":"M Gnecchi","year":"2005","journal-title":"Nat Med"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1096\/fj.06-6558com","article-title":"SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.","volume":"21","author":"M Zhang","year":"2007","journal-title":"FASEB J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neulet.2008.10.040","article-title":"Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration.","volume":"448","author":"D Gordon","year":"2008","journal-title":"Neurosci Lett"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1073\/pnas.0337659100","article-title":"Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains.","volume":"100","author":"JM Weimann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/NEN.0b013e3181f97392","article-title":"Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis.","volume":"69","author":"D Gordon","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1227\/01.NEU.0000181369.76323.50","article-title":"Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats.","volume":"57","author":"A Mahmood","year":"2005","journal-title":"Neurosurgery"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","article-title":"Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.","volume":"65","author":"I Kassis","year":"2008","journal-title":"Arch Neurol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1097\/01.CCM.0000285992.99391.7E","article-title":"Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia.","volume":"35","author":"T Wang","year":"2007","journal-title":"Crit Care Med"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases.","volume":"299","author":"RK Burt","year":"2008","journal-title":"JAMA"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0026098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T18:54:35Z","timestamp":1593111275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0026098"}},"subtitle":[],"editor":[{"given":"Cesario V.","family":"Borlongan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,7]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0026098","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,7]]}}}